We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NAKA:NASDAQKindly MD, Inc. Analysis

Data as of 2026-05-23 - not real-time

$7.23

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Nakamoto Inc. (NAKA) is trading at $7.23, well below its 20‑day SMA of 7.22 and far under the 200‑day SMA of 59.45, signaling a bearish long‑term trend. The RSI sits near the mid‑range at 45.7 and the MACD histogram has turned slightly positive, giving a modest bullish signal on short‑term momentum. Volatility is extreme at 96.6% over the past 30 days and the stock’s beta of 2.74 indicates it moves almost three times the market, while the max drawdown of –99.37% underscores historic price collapse. Support rests around $5.77 and resistance near $8.80, with volume remaining stable despite a market cap of only $126 M.
Fundamentally, the company posts zero gross margin, a –10.5% operating margin and negative EPS of –$18.80, carries $210 M of debt versus $35 M of cash, and trades at a price‑to‑book of 6.16 and price‑to‑sales of 44, suggesting it is significantly overvalued. Recent material events include a 1‑for‑40 reverse split to satisfy Nasdaq’s $1 bid price rule, a merger with Nakamoto Holdings, and active management of its BTC treasury, all aimed at stabilizing the share price. Despite a “strong buy” analyst consensus and a target price of $30, the lack of earnings, high leverage, and crypto‑centric regulatory exposure make the outlook highly speculative.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Technical momentum showing slight bullishness
  • Proximity to support level
  • Extreme price volatility

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Potential upside from merger and BTC treasury strategy
  • Analyst target price of $30
  • Improved share price after reverse split

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Sustained negative earnings and cash flow
  • High debt load relative to cash
  • Regulatory uncertainty surrounding crypto‑related businesses

Key Metrics & Analysis

Financial Health

Revenue Growth177.10%
ROE-157.33%
ROA-6.41%
Debt/Equity57.24
P/B Ratio6.2
Op. Cash Flow$-45931500
Free Cash Flow$-5334556
Industry P/E16.8

Technical Analysis

TrendBearish
RSI45.7
Support$5.77
Resistance$8.80
MA 20$7.22
MA 50$8.50
MA 200$59.45
MACDBullish
VolumeStable
Fear & Greed Index91.61

Valuation

Target Price$30.00
Upside/Downside314.94%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.74
Volatility96.64%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.